MedPath

The safety evaluation of endoscopic therapy against patients receiving anticoagulants agents.

Not Applicable
Recruiting
Conditions
Patients undergoing gastrointestinal endoscopic therapy during anticoagulant therapy
Registration Number
JPRN-UMIN000025164
Lead Sponsor
Osaka Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(A)INR exceeding the upper limit shown in the guideline by Japanese circulation society. (B)The patient who takes other antiplatelet agents

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gastrointestinal bleeding during two weeks after endoscopic therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath